ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 87 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,173,000 | -17.5% | 229,347 | 0.0% | 0.74% | +44.4% |
| Q2 2019 | $1,422,000 | +190.2% | 229,347 | +233.1% | 0.51% | +435.8% |
| Q1 2019 | $490,000 | -16.7% | 68,847 | 0.0% | 0.10% | -73.9% |
| Q4 2018 | $588,000 | -59.7% | 68,847 | -5.5% | 0.36% | -74.5% |
| Q3 2018 | $1,458,000 | -22.5% | 72,840 | 0.0% | 1.43% | +83.0% |
| Q2 2018 | $1,881,000 | -76.5% | 72,840 | -78.3% | 0.78% | -86.0% |
| Q1 2018 | $8,019,000 | +191.1% | 335,541 | +312.8% | 5.58% | -0.1% |
| Q4 2017 | $2,755,000 | -83.0% | 81,285 | -89.4% | 5.58% | -66.9% |
| Q3 2017 | $16,172,000 | – | 763,927 | – | 16.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 808,431 | $3,501,000 | 2.68% |
| AIGH Capital Management LLC | 875,851 | $3,793,000 | 1.54% |
| Healthcare Value Capital, LLC | 100,000 | $433,000 | 1.46% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 440,955 | $1,909,000 | 1.11% |
| Opaleye Management Inc. | 1,487,800 | $6,442,000 | 0.84% |
| Worth Venture Partners, LLC | 225,106 | $975,000 | 0.77% |
| ARMISTICE CAPITAL, LLC | 2,742,000 | $11,873,000 | 0.40% |
| DELTEC ASSET MANAGEMENT LLC | 245,399 | $1,063,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 278,011 | $1,204,000 | 0.15% |
| Mosaic Family Wealth, LLC | 91,807 | $398,000 | 0.13% |